Clinical significance of NOB1 expression in breast infiltrating ductal carcinoma.
CONCLUSIONS: In summary, our present study clarify that the aberrant expression of NOB1 in breast infiltrating ductal carcinoma is possibly involved with tumorigenesis and development, and the NOB1 protein could act as a potential biomarker for prognosis assessment of breast infiltrating ductal carcinoma. Related mechanism is worthy of further investigation.
PMID: 24133592 [PubMed - in process]
Source: Clinical Breast Cancer - Category: Cancer & Oncology Authors: Li XY, Luo QF, Li J, Wei CK, Kong XJ, Zhang JF, Fang L Tags: Int J Clin Exp Pathol Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Ductal Carcinoma | Genetics | Study